Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is a growing concern worldwide, affecting 25% of the global population. NAFLD is a multifactorial disease with a broad spectrum of pathology includes steatosis, which gradually progresses to a more severe condition such as nonalcoholic steatohepatitis (NASH),...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/8/4282 |
id |
doaj-c2348a9cb2d9491f82cbdceb1c6a9fed |
---|---|
record_format |
Article |
spelling |
doaj-c2348a9cb2d9491f82cbdceb1c6a9fed2021-04-20T23:04:47ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-04-01224282428210.3390/ijms22084282Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseChander K. Negi0Sabbir Khan1Hubert Dirven2Lola Bajard3Luděk Bláha4Faculty of Science, RECETOX, Masaryk University, Kamenice 5, CZ62500 Brno, Czech RepublicDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USADepartment of Environmental Health, Section for Toxicology and Risk Assessment, Norwegian Institute of Public Health, 0456 Oslo, NorwayFaculty of Science, RECETOX, Masaryk University, Kamenice 5, CZ62500 Brno, Czech RepublicFaculty of Science, RECETOX, Masaryk University, Kamenice 5, CZ62500 Brno, Czech RepublicNonalcoholic fatty liver disease (NAFLD) is a growing concern worldwide, affecting 25% of the global population. NAFLD is a multifactorial disease with a broad spectrum of pathology includes steatosis, which gradually progresses to a more severe condition such as nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and eventually leads to hepatic cancer. Several risk factors, including exposure to environmental toxicants, are involved in the development and progression of NAFLD. Environmental factors may promote the development and progression of NAFLD by various biological alterations, including mitochondrial dysfunction, reactive oxygen species production, nuclear receptors dysregulation, and interference in inflammatory and immune-mediated signaling. Moreover, environmental contaminants can influence immune responses by impairing the immune system’s components and, ultimately, disease susceptibility. Flame retardants (FRs) are anthropogenic chemicals or mixtures that are being used to inhibit or delay the spread of fire. FRs have been employed in several household and outdoor products; therefore, human exposure is unavoidable. In this review, we summarized the potential mechanisms of FRs-associated immune and inflammatory signaling and their possible contribution to the development and progression of NAFLD, with an emphasis on FRs-mediated interferon signaling. Knowledge gaps are identified, and emerging pharmacotherapeutic molecules targeting the immune and inflammatory signaling for NAFLD are also discussed.https://www.mdpi.com/1422-0067/22/8/4282flame retardantsnonalcoholic fatty liver diseasemetabolism-disrupting chemicalscytokinesinterferonmetabolic disruption |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chander K. Negi Sabbir Khan Hubert Dirven Lola Bajard Luděk Bláha |
spellingShingle |
Chander K. Negi Sabbir Khan Hubert Dirven Lola Bajard Luděk Bláha Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease International Journal of Molecular Sciences flame retardants nonalcoholic fatty liver disease metabolism-disrupting chemicals cytokines interferon metabolic disruption |
author_facet |
Chander K. Negi Sabbir Khan Hubert Dirven Lola Bajard Luděk Bláha |
author_sort |
Chander K. Negi |
title |
Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease |
title_short |
Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease |
title_full |
Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease |
title_fullStr |
Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease |
title_full_unstemmed |
Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease |
title_sort |
flame retardants-mediated interferon signaling in the pathogenesis of nonalcoholic fatty liver disease |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-04-01 |
description |
Nonalcoholic fatty liver disease (NAFLD) is a growing concern worldwide, affecting 25% of the global population. NAFLD is a multifactorial disease with a broad spectrum of pathology includes steatosis, which gradually progresses to a more severe condition such as nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and eventually leads to hepatic cancer. Several risk factors, including exposure to environmental toxicants, are involved in the development and progression of NAFLD. Environmental factors may promote the development and progression of NAFLD by various biological alterations, including mitochondrial dysfunction, reactive oxygen species production, nuclear receptors dysregulation, and interference in inflammatory and immune-mediated signaling. Moreover, environmental contaminants can influence immune responses by impairing the immune system’s components and, ultimately, disease susceptibility. Flame retardants (FRs) are anthropogenic chemicals or mixtures that are being used to inhibit or delay the spread of fire. FRs have been employed in several household and outdoor products; therefore, human exposure is unavoidable. In this review, we summarized the potential mechanisms of FRs-associated immune and inflammatory signaling and their possible contribution to the development and progression of NAFLD, with an emphasis on FRs-mediated interferon signaling. Knowledge gaps are identified, and emerging pharmacotherapeutic molecules targeting the immune and inflammatory signaling for NAFLD are also discussed. |
topic |
flame retardants nonalcoholic fatty liver disease metabolism-disrupting chemicals cytokines interferon metabolic disruption |
url |
https://www.mdpi.com/1422-0067/22/8/4282 |
work_keys_str_mv |
AT chanderknegi flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease AT sabbirkhan flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease AT hubertdirven flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease AT lolabajard flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease AT ludekblaha flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease |
_version_ |
1721517182758682624 |